Cigarette Reduction Using the Quitbit Digital Lighter and Mobile Application for Smoking Cessation: a Randomized Controlled Trial

The study is designed to evaluate the efficacy of a cigarette reduction intervention using a novel device called the Quitbit, a digital lighter paired with a smartphone mobile application, to enhance self-regulatory techniques for reducing cigarettes smoked per day toward cessation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Health Behavior Self-Control Social Behavior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, San Francisco

San Francisco, California, 94122, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age
cigarette smoker
wanting to quit in the next 30 days
preference to quit gradually (vs. abruptly) or having no preference
access to an iPhone (iOS only)
completion of a run-in period

Exclusion criteria

no major change in number of cigarettes per day in the past month (+/- 20%)
no major health diagnoses that could impact study attrition

Treatment and study plan

Gradual Cessation

Behavioral

Other names: Cigarette Reduction

Gradual Cessation w/ Quitbit

Behavioral

Other names: Cigarette Reduction w/ Quitbit

Primary outcomes

Saliva cotinine level

Time frame: 6 Months

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

Quitbit, Inc.

Registry information

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Aug 4, 2015
Registry last updated: Jan 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed